Cresco Labs Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Cresco Labs kazanç ve gelirinin sırasıyla yıllık 137.8% ve 7.1% oranında artması tahmin edilirken, EPS'nin yıllık 104.2% oranında büyümesi bekleniyor.

Anahtar bilgiler

137.8%

Kazanç büyüme oranı

104.2%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi54.4%
Gelir büyüme oranı7.1%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Good

Son güncelleme30 Oct 2024

Gelecekteki son büyüme güncellemeleri

Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Aug 11
Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Mar 16
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Recent updates

Getting In Cheap On Cresco Labs Inc. (CSE:CL) Is Unlikely

Oct 24
Getting In Cheap On Cresco Labs Inc. (CSE:CL) Is Unlikely

Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Aug 11
Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?

Jul 17
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?

Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden

Jun 19
Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden

Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 19
Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Mar 16
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Mar 03
Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Jan 26
Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Jan 04
Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Is Cresco Labs (CSE:CL) Using Too Much Debt?

Sep 22
Is Cresco Labs (CSE:CL) Using Too Much Debt?

Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Aug 11
Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Jan 25
Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

Dec 13
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Aug 22
We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

May 23
Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

Kazanç ve Gelir Büyüme Tahminleri

CNSX:CL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026853N/AN/AN/A1
12/31/2025777-1601048
12/31/2024743-56641098
6/30/2024735-1725991N/A
3/31/2024747-1554892N/A
12/31/2023756-176159N/A
9/30/2023767-339-165N/A
6/30/2023786-234-2350N/A
3/31/2023806-211-4425N/A
12/31/2022825-212-6719N/A
9/30/2022842-65-3853N/A
6/30/2022848-326-6234N/A
3/31/2022841-318-114-2N/A
12/31/2021806-320-8314N/A
9/30/2021750-360-99-3N/A
6/30/2021687-73-7420N/A
3/31/2021573-105-2543N/A
12/31/2020463-102-97-8N/A
9/30/2020345-76-149-34N/A
6/30/2020231-98-186-70N/A
3/31/2020168-64-185-57N/A
12/31/2019124-43-121-25N/A
9/30/2019101-20-94-29N/A
6/30/201978-14-67-20N/A
3/31/201957-12-53-16N/A
12/31/201841-2-40-10N/A
9/30/2018280-26-4N/A
6/30/2018191-23-7N/A
3/31/2018131N/A-6N/A
12/31/201710-3N/A-5N/A
12/31/20163-8N/A-11N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CL önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: CL önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: CL önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: CL şirketinin gelirinin (yıllık 7.1% ) Canadian pazarından (yıllık 6.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CL şirketinin gelirinin (yıllık 7.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CL 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok


Büyüyen şirketleri keşfedin